Background: Familial hypercholesterolemia (FH) is associated with a high risk of coronary heart disease. Pharmacological treatment and diet are both essential for the management of FH. Foods rich in plant sterols (PS) may play an important role in the treatment of patients with these disorders. Objective: To test the effect of the intake of PS on low-density lipoprotein (LDL) concentration, endothelial function (EF) and LDL particle size in 30 patients with FH. Design: Randomized and crossover dietary intervention study. Setting: Tertiary outpatient care. Subjects: Thirty-eight were recruited, but only 30 were subjected to four low-fat dietary intervention periods, each of 4 weeks. Methods: Each intervention had a different content of cholesterol (o150 or 300 mg/day) and sitosterol (o1 or 2 g/day). Lipid response, EF and LDL particle size were analysed after the intervention. Results: Plasma sitosterol/cholesterol ratio was higher during both plant sterol-rich periods than during the low plant sterols periods. Basal sitosterol concentrations predicted the LDL-cholesterol response during the intake of plant sterol-enriched diets. The change in LDL-cholesterol was significantly greater in subjects in the upper and intermediate tertiles of basal plasma sitosterol concentrations (À2178 mg/dl, P ¼ 0.03; À1977 mg/dl, P ¼ 0.04, respectively) than in subjects in the lower tertile (875 mg/dl) when they changed from a low cholesterol diet to a low cholesterol plus plant sterol diet. Conclusion: Our study demonstrates that basal sitosterol values can predict hypolipidemic response in patients with FH.
Introduction
Familial hypercholesterolemia (FH) is a genetic disorder that increases the risk of death from cardiovascular disease.
The management of this disorder thus inevitably hinges on aggressive hypolipidemic treatment (Alonso et al., 2002; Civeira et al., 2004) .
Foods enriched with plant sterols (PS) induce specific effects on plasma cholesterol by lowering low-density lipoprotein (LDL)-cholesterol concentrations. Phytosterols are structurally related to cholesterol, and they inhibit the absorption of dietary cholesterol and the reabsorption of biliary cholesterol from the intestine due to their higher affinity for mixed micelles compared with cholesterol (Ling and Jones, 1995) . Earlier studies suggest that the use of PS could enhance the effect of statins (Neil et al., 2001; Hendrinks et al., 2003; Noakes et al., 2004; O'Neill et al., 2005; Patch et al., 2005) . Although still unevaluated in patients with FH, genetic variation and other associated factors have been found to determine the response of plasma cholesterol to dietary fat composition (Hill et al., 1991; Jansen et al., 1998; Pérez-Martínez et al., 2001; Marks et al., 2003) . It is also controversial whether the effects of PS on lipoproteins depend on the composition of the diet, particularly on the intake of cholesterol. Although some investigators reported that low levels of dietary cholesterol intake attenuate the effectiveness of phytostanols, others have shown that phytosterols lower cholesterol concentrations even in subjects in whom cholesterol intake is severely restricted. We exploited this aspect in designing the present study to explain this issue in FH patients.
To date, the majority of reviews regarding the cholesterollowering capacity of phytosterols have focused on normoand hypercholesterolemic patients. However, the effect of the intake of such foods on lowering LDL-cholesterol (LDL-C) varies between individuals, and little research has been done on populations with very high cholesterol levels, such as FH (Chisholm et al., 1994; Vuorio et al., 2000) . A metaanalysis that recently analysed this issue concluded that PS may offer an effective adjunct to the cholesterol-lowering strategy for treating FH patients, as PS may produce a mean decrease of 10-15% in LDL-C (Moruisi et al., 2006) .
One of the determining factors of impairment in endothelial function (EF) is hypercholesterolemia. Statin treatment has been shown to improve endothelial dysfunction in adults with FH (Brown et al., 2004) . However, little research has been done on the effects of PS on EF in these patients. A recent report investigated the role of plant sterols/stanols on EF in hypercholesterolemic patients and the associations with cholesterol metabolism variables. The authors concluded that EF was associated with elevated synthesis and low absorption of cholesterol, whereas EF decreased slightly during the PS period and remained unchanged during control and plant stanol periods (Hallikainen et al., 2006) . Another major cardiovascular risk factor is the presence of small dense LDL particles . However, there are currently only limited data on the individual effects of phytosterols on the characteristics of the LDL particle size phenotype (Matvienko et al., 2002; Charest et al., 2004) . More studies on the effects of the intake of dietary PS on LDL particle size are needed.
The aim of this study was to assess the effect of the intake of foods enriched in PS on LDL-C concentrations, EF and LDL particle size in patients with FH.
Materials and methods

Population
The study population initially consisted of 38 patients selected from the Familial Hypercholesterolemia Cohort and the FH National Register, both compiled by the Familial Hypercholesterolemia Foundation (http://www. colesterolfamiliar.com). Inclusion criteria were as follows: heterozygous FH diagnosed on the basis of genetic and/or clinical diagnosis and a score of X8 points (WHO MedPed criteria WHO, 1999) ; absence of a personal history of coronary disease; age between 18 and 75; absence of any other disease that might affect lipid metabolism; apoE E3/E3 genotype characterized as in our previous studies (Ló pezMiranda et al., 2004) ; LDL-C levels above 130 mg/dl; and triglycerides below 200 mg/dl. The inclusion criterion of the apoE E3/E3 genotype was adopted to eliminate the influence of this genetic variant on the lipid response to the diets. All patients had to take a stable dose of statin from 8 weeks before the beginning of study. Throughout the study, no changes were made in the doses or types of statins (19 were treated with 40 mg of atorvastatin and 19 with 40 mg of simvastatin) administered to the patients and without another drug that might have altered lipid levels during the study. Patients who required changes in their dosage of statins (2) or decided to withdraw for personal reasons (3) were excluded from the study. Physical activity and diet, including alcohol consumption, were recorded in a personal log for 1 week, and the data were used to calculate individual energy requirements. Subjects were encouraged to maintain their regular physical activity and lifestyle and were asked to record any event that might have affected the outcome of the study in a diary, such as changes in stress levels, change in smoking habits and alcohol consumption, and the intake of foods not included in the experimental design. Patients were also excluded from the study if their physical activity levels were significantly above average or they drank more than 20 g of alcohol per day (3). The final study sample thus consisted of 30 patients. The study protocol was approved by the Human Investigation Review Committee of the Reina Sofia University Hospital.
Study design
Patients underwent four dietary intervention periods, each of which lasted for 4 weeks following a randomized crossover Latin-square design. To keep the weight of the patients stable, the diets were isocaloric with respect to each patient's previous caloric intake. All four diets were low-fat diets, providing o30% fat, o10% saturated fat, 6% polyunsaturated fatty acids (PUFA), 12% monounsaturated fatty acids (MUFA), 55% carbohydrate and 15% protein, with different amounts of cholesterol and PS: 150 mg/day CHO and o0.5 g/day PS (low-CHO diet); 280-300 mg/day CHO and o0.5 g/day PS (CHO diet); 150 mg/day CHO and 2.5 g/day PS (low-CHO þ SIT diet); 280-300 mg/day CHO and 2.5 g/day PS (CHO þ SIT diet). We administered PS using fat spreads as vehicle. The study design is illustrated in Table 1 . The macronutrient content of the diets is shown in Table 2 .
Dietary cholesterol content was kept within the limits recommended by international organizations (USDA) for the dietary treatment of hypercholesterolemia (Civeira et al., 2004) . Likewise, weight, height and body mass index (BMI) were measured weekly during each dietary period.
On the basis of the questionnaires concerning the frequency of types of food consumed and of the four 3-day dietary records (one for each season of the year) registered for these patients in the Spanish HF cohort, we calculated their mean caloric intake and the distribution of macronutrients in the normal diet, and maintained the same macronutrient distribution throughout the four intervention periods. The four diets were designed to be isocaloric, to avoid significant weight losses. The diet consisted of 20 previously established menus that were administered on a rotating basis. They were prepared using natural foods and were balanced to provide the proportions established for each dietary period. The meals were given to the study participants in a restricted area in the Hospital and were supervised by a dietician. Lunch and dinner were eaten in the hospital dining room, and breakfast and an afternoon snack were eaten in the medical school cafeteria. Twenty menus were prepared with regular solid foods and were rotated during the experimental period. The dietician explained the diets to the patients and on days 15 and 28 of each diet gave them a log-book covering 3 days. In the course of her visits she took the opportunity to emphasize her recommendations and to ensure that they were being followed.
Analytical determinations
At the end of each of the dietary intervention periods and after a 12-h fast, 30 ml of venous blood was extracted into tubes containing 1 mg/ml ethylenediaminetetraacetic acid. Another 30 ml of venous blood was extracted into tubes containing 3.8% sodium citrate. Lipid parameters were assessed with the modular autoanalyzer DDPPII Hitachi (Roche, Basle, Switzerland), using specific reagents (BoehringerMannheim, Mannheim, Germany). Total cholesterol and triglyceride concentrations were determined by colorimetric, enzymatic methods (Bucolo and David, 1973; Allain et al., 1974) . High-density lipoprotein cholesterol levels were measured by means of colorimetric assays after precipitating the lipoproteins containing apolipoprotein B with polyethylene glycol (Briggs et al., 1981) . LDL-C levels were estimated using the Friedewald formula based on the values of cholesterol (CT), triglycerides (TG), and high-density lipoprotein cholesterol (Friedewald et al., 1972) . Apolipoprotein Al and apolipoprotein B levels were measured by immunoturbidimetry (Riepponen et al., 1987) . Plant sterols were measured by gas chromatography (Abidisy, 2004) .
Study of endothelial function using laser Doppler
At the end of each dietary intervention period, variations in skin capillary flow were analysed using laser Doppler flowmetry. This non-invasive method measures the vasodilation in skin microcirculation following ischemia. The Periflux 5000 (Perimed, Stockholm, Sweden) laser Doppler flowmetry kit was used. After a 15-min rest and with the patient in a fasting state, studies were performed in a quiet room at a stable temperature (221C) to put the patient at ease. Patients lay supine and a laser probe was attached to the second phalanx of their index finger. Patients were tested at the same time of day (between 0800 and 1000) by two observers who were blind to the assignment of subjects to the treatment conditions. After another rest, basal capillary 
Abbreviations: CHO diet, low-fat and high-cholesterol diet; CHO þ SIT diet, low-fat, high-cholesterol and sitosterol-enriched diet; low-CHO diet, low-fat diet; low-CHO þ SIT diet, low-fat, low cholesterol and sitosterol-enriched diet. Table 2 Macronutrient's content of the diet Abbreviations: CHO diet, low-fat and high-cholesterol diet; CHO þ SIT diet, low-fat, high-cholesterol and sitosterol-enriched diet; low-CHO diet, low-fat diet; low-CHO þ SIT diet, low-fat, low cholesterol and sitosterol-enriched diet; SFA, saturated fatty acids.
a Plant sterols provided were 7.5 g/100 g of fat spread and sitosterol was the principal component, representing about 90% of the total. The proportions of other sterols were as follows: cholestanol 2%, stigmasterol 2%, lathosterol 3%, campesterol 1.5%, lanosterol 0.5%, others 1%.
Prediction of LDL-C response to sitosterol in FH patients F Fuentes et al flow was measured. Ischemia was induced by pneumatic compression to a pressure of no less than 220 mm Hg for 4 min, using a blood-pressure cuff applied to the patient's arm. The cuff was allowed to deflate for 30 s and the flow was measured again to determine endothelium-mediated vasodilation.
Study of LDL particle size As described previously, the major peak LDL diameter (LDL size) was measured using samples of serum with 2-16% polyacrylamide gel (Krauss and Blanche, 1992) . The resulting gel was scanned and analysed using the Scion Image for Windows programme (Scion Corporation, Frederick, MD, USA). LDL particle size was determined by interpolating LDL migration versus migration on a regression curve (pattern size in nm).
Statistical analysis
All variables except triglycerides were normally distributed. An analysis of variance (ANOVA) for repeated measures (homogeneity of variance) was used to determine the effect of diet on individual parameters. When significant differences were observed, Tukey's post hoc comparison test was used to identify between-group changes. Interactions between the type of diet and the order of administration were assessed for each variable, using a general linear mixed model, with the order of administration of diet as a covariate. All the variables were normally distributed and we performed an ANOVA for repeated measures, utilizing the value of P with the test for the presumption of sphericity. When the analysis did not demonstrate sphericity, we utilized the Greenhouse-Geisser test to find the value of P. Multiple regression analysis was used to verify the variables that predicted hypolipidemic response, using as the dependent variable baseline sitosterol concentrations and other variables that were entered into the regression model: BMI, PS/CHO quotient, and changes in LDL-C concentrations. A correlation analysis was performed to determine the association between the main variables. Data are presented as mean7s.d. Statistical significance was determined by a P-value of less than 0.05. Data were analysed using SPSS for Windows Release 11 (2001).
Results
The baseline characteristics of patients are presented in Table 3 . Body weights and BMI did not change during the study. The concentrations of individual lipid parameters, sitosterol, sitosterol/cholesterol ratio (PS/CHO), EF, LDL particle size, and BMI for each intervention period are presented in Table 4 . There were no differences resulting from the order of administration of diets in the analysis. PS concentrations did not differ. The PS/CHO ratio was significantly higher during the sterol-enriched diets than in other intervention periods. No significant differences were seen in LDL-C when end values were compared. A significant reduction in LDL-C concentrations was revealed when the diets changed from high cholesterol diet (CHO diet) to the low-fat, high-cholesterol and PS-enriched diet (CHO þ SIT diet) (À9.67s.d. mg/dl vs 2 mg/dl, Po0.05; À5.7 vs 2.1%, Po0.05). Interestingly, basal sitosterol values predicted the change in LDL cholesterol concentrations after the consumption of a sitosterol-rich diet (low-CHO þ SIT diet), both in absolute values (r ¼ 0.347, Po0.03) and in the percentage reduction in LDL cholesterol (r ¼ 0.364, Po0.02). This finding suggests that basal sitosterol concentrations can be used to a certain extent to predict the hypocholesterolemic response in treatments employing plant sterol-enriched foods. Patients in the upper tertile of basal plasma sitosterol levels displayed a greater decrease in LDL-C concentrations (À21 mg/dl; À13%) than those in the lower tertile (8 mg/dl; 5%) and changes were also seen in patients in the intermediate tertile than in those in the lower tertile (À19 mg/dl; À12%) (Figure 1 ). The study of EF using laser Doppler flowmetry found no differences between any of the four dietary intervention periods (Table 4 ). Compared to both the low-CHO and CHO diets, LDL particles were both larger and less dense after the two PS-enriched dietary periods (Table 4 ). There was a significant correlation between the changes in LDL-C concentrations and LDL particle size after the consumption of PS-enriched diets (CHO þ SIT diet and low-CHO þ SIT Prediction of LDL-C response to sitosterol in FH patients F Fuentes et al diet). When patients switched from a low-CHO diet to a CHO þ SIT diet, a positive correlation was found between the changes in LDL concentrations and LDL size (r ¼ 0.461, Po0.012). Likewise, when they switched from a low-CHO diet to a SIT diet, changes in LDL concentrations and LDL size were also positively correlated (r ¼ 0.395, Po0.034).
Discussion
The main finding of our study was that subjects with heterozygous FH with high basal concentrations of PS, indicative of efficient cholesterol absorption, showed a greater reduction in LDL-C than those with lower basal PS concentrations, as already reported by other authors in non-FH patients. This suggests that when PS are added to a low-fat diet, basal sitosterol plasma concentrations could partially predict decreases in LDL-C concentrations in FH patients treated with statins. Moreover, LDL particles become larger and less dense with this diet. In this study, the therapeutic use of plant sterol-enriched foods reduced LDL-C plasma concentrations. However, wide discrepancies have been found in different studies conducted on this topic (Law, 2000; O'Neill et al., 2004) . Little information has been obtained from studies of the effects of PS and stanol-enriched foods in populations with genetic dyslipemia (Amudsen et al., 2004) . A meta-analysis of 14 randomized, double-blind trials found that the relation between hypolipidemic response and the dosage of sterol administered to the patient (up to 2 g per day) contributed to an average reduction in LDL-C concentrations of 13-17% (Law, 2000) . Similarly, another meta-analysis of six studies (Moruisi et al., 2006) investigated the efficacy of phytosterols/stanols in lowering LDL-C concentrations in FH subjects and found a 10-15% reduction in LDL-C concentrations.
In other studies, the LDL-C response is not as clear-cut, with results showing a reduction of only 4-8% (O'Neill et al., 2004) or a 5.4% reduction in LDL-C concentration in the whole sample of mild to moderate hypercholesterolemic patients (Mussner et al., 2002) . We found a 5.7% decrease in LDL-C concentrations after intervention. This fact disagrees with another report (Denke, 1995) , which claimed that a low level of dietary cholesterol attenuates the effectiveness of a low-dose phytostanol therapy, although other studies found that phytosterols can lower serum cholesterol concentrations even in subjects with a low cholesterol intake (Hallikainen and Uusitupa, 1999; O'Neill et al., 2005) , a finding that was not confirmed in our study. This can be Figure 1 Changes in low-density lipoproteins-cholesterol levels (mg/dl) on changing from a low-CHO diet to a CHO diet (1), a CHO þ SIT diet (2) and a low-CHO þ SIT diet (3), according to the basal plasma sitosterol tertiles. ANOVA for repeated measures.
Prediction of LDL-C response to sitosterol in FH patients F Fuentes et al explained by the fact that phytosterols inhibit the absorption of dietary and biliary cholesterol from the intestine. Some clinical trials have shown that PS reduce LDL-C concentrations regardless of the quantity of cholesterol and quantity and type of dietary saturated fat (Weststrate and Meijer, 1998; Hendriks et al., 1999; Hallikainen et al., 2000) . Not only cholesterol intake but also the rate of cholesterol absorption may influence the effectiveness of phytosterol esters. One study indicated that subjects with high baseline absorption of cholesterol benefit less from long-term simvastatin treatment than subjects with a lower baseline rate of absorption . Subjects with high baseline cholesterol absorption may be prime candidates for a combined treatment with a statin and phytosterols. owing to either an excessive intake of dietary cholesterol or genetic influence, the opposite result is found in FH patients who respond poorly to statin treatment. These cases show lower rates of endogenous cholesterol synthesis after increased cholesterol absorption. In such cases, adding sterols to pharmacological treatment results in an improvement in the reduction of LDL-C levels (Law, 2000) .
An interesting aspect of our results is the predictive value of the plasma basal sitosterol concentrations in the hypolipidemic response (LDL-C reduction). When patients with basal plasma sitosterol in the upper tertile were compared with the group in the lower tertile, we observed a 13% reduction in LDL-C (Figure 1 ). This finding suggests that, on the basis of a patient's basal sitosterol, it is possible to select candidates who would be suitable for plant sterol-enriched foods. These patients behave like hyperabsorbers, and high sitosterol diets boost the effect on reduction of LDL-C. However, various other biochemical and genetic mechanisms that have not yet been fully identified could also affect this response.
The intake of PS did not affect EF in this study. These results are similar to findings reported by other authors (De Jongh et al., 2003; Rodenburg et al., 2004) , although significant reductions in LDL cholesterol values were also described in these studies. However, larger, less dense LDL particles appeared after the sterol-enriched diet in this study. This finding suggests that this type of diet might be beneficial as a means of reducing cardiovascular risk in FH patients. However, a similar study (Varady et al., 2005) did not find a similar result in patients with moderate hypercholesterolemia. The effect on LDL particle size of a diet low in saturated fat, rich in PS and supplemented with plant proteins (soya), almonds and viscous fibre was studied in a group of 12 patients with moderately high levels of LDL-C . The results of the study showed a reduction in all LDL fractions, including small dense particles. Another report (Charest et al., 2004) has shown that in moderately hypercholesterolemic subjects, consumption of PS as butter did not induce significant changes in LDL particle size, and the phytosterol-induced reduction in LDL-C concentrations was attributable only to a reduction in the cholesterol content of large LDL particles, with no change in the cholesterol concentrations of small particles. We hypothesize that the phytosterol content of these diets may have been responsible for the reduction in the cholesterol content within large LDL particles. The possibility cannot be completely excluded that part of the diet-induced changes in LDL size phenotype are attributable to other differences between the baseline and the experimental diets, such as levels of dietary cholesterol and of saturated fatty acids.
In conclusion, our findings demonstrate that combined statin and plant sterol treatment and a low-fat diet can reduce LDL-C levels in FH patients. Furthermore, basal plasma sitosterol levels may be able to at least partially predict a reduction in levels of LDL-C.
